Introduction {#s1}
============

*Pseudomonas aeruginosa* is an opportunistic pathogen that causes severe chronic infections in immunocompromised patients and other risk groups, such as cystic fibrosis (CF) or chronic obstructive pulmonary disease (COPD) patients. The key to *P. aeruginosa* survival in environments that range from soil to various living host organisms is its metabolic versatility. It subsists on various carbon sources for energy, uses nitrogen as a terminal electron acceptor under anaerobic conditions, requires minimal nutrients, and grows at temperatures up to 42°C. *P. aeruginosa* uses anaerobic metabolism to reduce nitrogen (N~2~) via the denitrification process (Schobert and Jahn, [@B28]; Arat et al., [@B3]), as an essential metabolic condition during chronic infection and biofilm growth (Yoon et al., [@B37]; Hassett et al., [@B15]; Crespo et al., [@B9]).

During *P. aeruginosa* infections, bacteria must multiply inside the infected organisms (plant, animal, insect, etc.), requiring active DNA synthesis for bacterial cell division. Ribonucleotide reductase (RNR) enzymes provide all living organisms with deoxyribonucleotide triphosphates (dNTP) supplying the monomers for DNA synthesis. Three different RNR classes exist (class I, subdivided into Ia, Ib, and Ic; class II and class III) that differ in their overall protein structure and cofactor requirements, but all possess allosteric regulation and use organic radicals to initiate catalysis through free radical chemistry (Jordan and Reichard, [@B19]; Cotruvo Jr and Stubbe, [@B7]; Hofer et al., [@B18]; Torrents, [@B32]). *P. aeruginosa* is one of the few organisms that encode three different RNR classes; the oxygen-dependent class Ia (encoded by the *nrdAB* genes), the oxygen-independent class II (encoded by the *nrdJab* genes) and the oxygen-sensitive class III (encoded by the *nrdDG* genes). Specifically, class II RNR activity depends on an external cofactor, adenosylcobalamin (AdoCob) or vitamin B~12~, to generate its radical independently of oxygen to reduce the different ribonucleotides to their corresponding deoxyribonucleotides.

Vitamin B~12~ is one of the most structurally complex cofactors synthesized by bacteria (Warren et al., [@B35]); however, not all microorganisms encode for the \~25 genes needed for the complete biosynthetic pathway. In nature, two vitamin B~12~ biosynthesis pathways exist: the aerobic, or late cobalt insertion pathway and the anaerobic, or early cobalt insertion pathway (Warren et al., [@B35]). One of the genes involved in the aerobic pathway that participates in cobalt insertion is the *cobN* gene described extensively in *Pseudomonas denitrificans* (Warren et al., [@B35]). The most studied anaerobic biosynthetic pathway involved in early cobalt insertion was described in *Salmonella typhymurium* (Roth et al., [@B27]).

*Pseudomonas* synthesizes vitamin B~12~ for different metabolic reactions, such as methionine synthesis, cobalamin biosynthesis, and RNR enzymes. One essential reaction is ribonucleotide synthesis by RNR. *P. aeruginosa* PAO1 has been demonstrated to grow in a filament cell morphology due to cellular stress by RNR activity depletion, such as the low expression levels of class III RNR under anaerobic conditions (Lee et al., [@B23]; Crespo et al., [@B8]) or the high nitric oxide levels in the denitrification process, which interacts with a cobalamin precursor of the vitamin B~12~ pathway (Broderick et al., [@B6]; Yoon et al., [@B36]; Sullivan et al., [@B31]). Therefore, this cell filamentation results from DNA replication impairment that affects *P. aeruginosa* PAO1 cell division, thus affecting infection (Sjöberg and Torrents, [@B29]; Crespo et al., [@B8]), anaerobic growth (Torrents et al., [@B33]; Torrents, [@B32]) and biofilm growth (Crespo et al., [@B9]). Class II and III RNR enzymes reduce ribonucleotides under these conditions. Thus, their activity is essential for cell division (Crespo et al., [@B9], [@B8]).

Class II RNR (NrdJab) activity is oxygen independent, but it strictly depends on vitamin B~12~ availability. To date, the link between internal vitamin B~12~ biosynthesis or availability from the environment and the real class II RNR activity is unknown. Therefore, in this work, we analyzed *P. aeruginosa* vitamin B~12~ biosynthesis during aerobic growth, anaerobic growth and biofilm formation. We also determined the relationship between vitamin B~12~ biosynthesis and class II RNR activity under different growing conditions.

Materials and methods {#s2}
=====================

Bacterial strains and growth conditions
---------------------------------------

*Pseudomonas aeruginosa* and *Escherichia coli* strains, listed in Table [1](#T1){ref-type="table"}, were grown in Luria-Bertani broth (LB) or minimum medium (MM) (Kjaergaard et al., [@B22]) at 37°C. MM containing 1% KNO~3~ (MMN) was used for anaerobic liquid growth in screw-cap tubes (Hungate tubes) (Garriga et al., [@B14]; Crespo et al., [@B9]) or in anaerobic plates using the GENbag system (bioMérieux) according to the manufacturer\'s instructions.

###### 

Strains and plasmids used in this study.

  **Strain or plasmid**           **Description**                                                               **Source**
  ------------------------------- ----------------------------------------------------------------------------- ------------------------------------
  **PLASMIDS**                                                                                                  
  pJET1.2/blunt                   *Blunt-end vector, AmpR*                                                      *Thermo Scientific*
  pUCGmlox                        Ap^R^, Gm^R^; source of Gm^R^ cassette                                        Hoang et al., [@B17]
  pEX18Tc                         *sac*B based counter-selection vector, Tc^R^                                  Hoang et al., [@B17]
  pETS160                         pBBR1 derivative carrying *nrdDG* operon, Gm^R^                               Sjöberg and Torrents, [@B29]
  pETS134                         pETS130 derivative carrying *nrdA* promoter, Gm^R^                            Sjöberg and Torrents, [@B29]
  pETS136                         pETS130 derivative carrying *nrdD* promoter, Gm^R^                            Sjöberg and Torrents, [@B29]
  pETS180                         pETS130 derivative carrying *nrdJ* promoter, Gm^R^                            Crespo et al., [@B10]
  **STRAINS**                                                                                                   
  ***E. coli***                                                                                                 
  DH5α                            *recA1 endA1 hsdR17 supE44 thi-1 relA1 Δ(lacZYA-argF)U169 deoR Φ80dlacZM15*   Lab stock
  S17.1 λ*pir*                    *recA thi pro hsdR- M+RP4::2-Tc::Mu::Km Tn7 Tpr Smr Xpir*                     de Lorenzo et al., [@B11]
  ***P. aeruginosa***                                                                                           
  PAO1                            Wild-type (ATCC 15692 / CECT 4122)- Spanish Type Culture Collection           Lab strain
  PA14                            Wild-type *P. aeruginosa* PA14                                                Lab strain
  PAET1                           *CF strain isolated from chronic patient*                                     Lab strain, (Crespo et al., [@B8])
  ETS102 (Δ***nrdJ***)            *P. aeruginosa* PAO1 *nrdJ*::ΩTc; Tc^R^                                       Sjöberg and Torrents, [@B29]
  ETS103 (Δ***nrdD***)            *P. aeruginosa* PAO1 *nrdD*::ΩTc; Tc^R^                                       Sjöberg and Torrents, [@B29]
  ETS125 (Δ***nrdJ**Δ**nrdD***)   *P. aeruginosa* PAO1 *nrdD*::ΩTc; Tc^R^, *nrdJ*::ΩGm; Gm^R^                   Crespo et al., [@B9]
  ETS126 (Δ***cobN***)            *P. aeruginosa* PAO1 *cobN*::ΩGm, Gm^R^                                       This work

The medium was supplemented, when necessary, with the following antibiotics: 100 μg/ml or 50 μg/mL gentamicin, 300 μg/ml carbenicillin and 40 μg/ml tetracycline for *P. aeruginosa*, and 10 μg/ml gentamicin and 50 μg/ml ampicillin for *E. coli*.

Construction of *cobN* deletion mutant strain
---------------------------------------------

*Pseudomonas aeruginosa* PAO1 with a mutation in the *cobN* gene (ETS126; Δ*cobN*) was constructed by inserting the gentamicin-resistance gene (*aacC1*) into the *cobN* gene by homologous recombination using the pEX18Tc vector, as previously described (Quenee et al., [@B24]; Sjöberg and Torrents, [@B29]). Briefly, two 400-bp areas surrounding the *P. aeruginosa* PAO1 *cobN* gene were amplified by PCR using the High-Fidelity PCR Enzyme Mix (Thermo Scientific) with the primer pairs, CobN1HIII-up/CobN2BI-low and CobN3BI-up/CobN4SI-low, listed in Table [2](#T2){ref-type="table"}. The two amplicons were cloned separately into the pJET1.2 vector (Thermo Scientific). A plasmid containing both fragments was generated by *BamHI/SacI* digestion. The gentamicin resistance gene *aacC1* was obtained using *Bam*HI digestion of pUCGmlox, and the corresponding cassette was ligated to the two fragments. The construct was cloned into the *sac*B gene-based counter-selection pEX18Tc vector and transferred into the S17.1λ*pir* strain for *P. aeruginosa* PAO1 conjugation as previously described (Crespo et al., [@B9]). Transconjugants were selected by plating them with tetracycline, gentamicin and sucrose (5%), used for *sacB*-mediated plasmid counter selection. *aacC1* insertion was screened and verified by PCR with the primer pair CobN1HIII-up/CobN5-low and later confirmed by DNA sequencing.

###### 

Oligonucleotides and probes used in this study.

  **Name**          **Sequence (5′ → 3′)**           **Application**
  ----------------- -------------------------------- -----------------
  pJET-rev          AAGAACATCGATTTTCCATGGCAG         Check-Cloning
  pJET-up           CGACTCACTATAGGGAGAGCGGC          Check-Cloning
  CobN1HIII-up      AAGCTTATGCACCTGTTGCGCACCC        Cloning
  CobN2BI-low       GGATCCCAGAAGCGCTCGGCCTGCT        Cloning
  CobN3BI-up        GGATCCTGAATCCGAAGTGGATCGC        Cloning
  CobN4SI-low       GAGCTCCTATTCCTCTTCCGACGTCCA      Cloning
  CobN5-low         CAGGCCAGGCCCTTGAAAC              Cloning
  gapTaqM-low       GAGGTTCTGGTCGTTGGT               qRT-PCR
  nrdATaqM2-low     TGTTCATGTCGTGGGTACG              qRT-PCR
  nrdJTaqM2-low     GTAAACACCCGCACCACTTC             qRT-PCR
  nrdDTaqM2-low     CCGAGTTGAGGAAGTTCTGG             qRT-PCR
  Univ-Res-Gen-lw   AAGAATTCACGCGTCGCTCATGAGACAATA   Cloning
  Univ-Res-Gen-up   AAGAATTCACGCGTATATATGAGTAAACTT   Cloning
  nrdA-FAM          CTGGCACCTGGACATC                 qRT-PCR probe
  nrdJ-FAM          TCGGCTCGGTCAACCT                 qRT-PCR probe
  nrdD-FAM          CCCGACCTACAACATC                 qRT-PCR probe
  gap-FAM           CCTGCACCACCAACTG                 qRT-PCR probe

Quantitative real-time PCR (qRT-PCR)
------------------------------------

Transcripts of RNR genes (*nrdA, nrdJ* and *nrdD*) were quantified using quantitative real-time PCR (qRT-PCR). *P. aeruginosa* was grown in planktonic conditions at the mid-exponential growth phase in which samples were treated with RNAprotect Bacterial Reagent (Qiagen). The RNeasy Mini Kit (Qiagen) was used to isolate and purify total RNA, and extra DNA was removed using DNase I (Turbo DNA-free, Applied Biosystems) per the manufacturer\'s instructions. DNA contaminations were verified by PCR. cDNA was synthetized using 0.5 μg of RNA with SuperScript III Reverse Transcriptase (Thermo Scientific). The primers used are listed in Table [2](#T2){ref-type="table"} (Crespo et al., [@B9]). RNA was quantified using a NanoDrop 1000 spectrophotometer (Thermo Scientific). The *gapA* gene was used to normalize the transcript gene levels.

Green fluorescent protein gene reporter assay
---------------------------------------------

GFP fluorescence expressed in plasmids, pETS134 (P*nrdA*), pETS180 (P*nrdJ*) and pETS136 (P*nrdD*), was measured to determine each RNR gene\'s promoter activity. *P. aeruginosa* containing the *nrd* promoter fusion was grown to exponential phase, and three independent 1-ml samples were analyzed. Cells were fixed with 1 ml of freshly prepared PBS 1x solution containing 2% formaldehyde (Sigma) and stored in the dark at 4°C. GFP fluorescence was measured in a 96-well plate (Costar® 96-Well Black Polystyrene Plate, Corning) on an Infinite 200 Pro Fluorescence Microplate Reader (Tecan), as previously described (Crespo et al., [@B10]). Three measurements were performed per independent sample.

Continuous-flow biofilm formation
---------------------------------

Continuous-flow cell biofilms were grown in MM + 0.2% glucose and performed as previously described (Baelo et al., [@B4]; Crespo et al., [@B9]). These *in vitro* formed biofilms are a more natural, mature biofilm with clear oxygen concentration stratification (Stewart and Franklin, [@B30]). Briefly, biofilms were grown in a three-channel flow cell with a constant flow rate of 42 μl per minute for each channel using an Ismatec ISM 943 pump (Ismatec). After 5 days of growth, biofilms were stained with the LIVE/DEAD BacLight Bacterial Viability Kit (Thermo Scientific) and visualized using a Zeiss LSM 800 confocal laser scanning microscope (CSLM). Images were generated using ImageJ Fiji software, and COMSTAT 2 software was used to quantify biomass and biofilm thickness (Heydorn et al., [@B16]).

Vitamin B~12~ quantification by HPLC-MS
---------------------------------------

*Pseudomonas aeruginosa* PAO1, PAET1, and PA14 strains were grown in MM or MMN medium for 20 h in aerobic or anaerobic conditions or for 5 days in a continuous-flow cell biofilm growth system. Cells were lysed using lysozyme (50 mg/ml) (Sigma) and sonicated five times on ice using a 6-mm sonication probe at 32% power for 20 s (Digital Sonifier, Branson). After centrifugation (4,000 × g at 4°C), the supernatants were filtrated with a 10-kDa Centricon column (Millipore). Samples were manipulated in the dark to avoid vitamin B~12~ degradation. Finally, 1% ammonium formate was added to each sample before HPLC-MS quantification. Samples of 10 μl were injected into the Luna 5-μm C18 100 Å (150 × 2 mm) column for HPLC-MS \[4000 QTRAP (AB SCIEX) in an Aligent 1,200 Series\] at the Separation Techniques platform of the Scientific Center Services of the Scientific Park of Barcelona (PCB). A calibration curve was constructed for vitamin B~12~ (Sigma) measured in the range of 0.1--100 ng/ml. Values were normalized, and the protein concentration was measured using a Bradford assay (Bio-Rad).

Fluorescence microscopic imaging and analysis
---------------------------------------------

*Pseudomonas aeruginosa* strain cultures were stained using the LIVE/DEAD BacLight viability kit (Thermo Scientific) for 15 min at room temperature in the dark. Fluorescent bacteria were visualized with a Nikon ECLIPSE Ti-S/L 100 inverted fluorescence microscope (Nikon) coupled with a Nikon DS-Qi2 camera. Live cells were visualized in green (SYTO 9 dye), and dead cells were visualized in red (propidium iodide dye). ImageJ software was used for image analysis.

Results and discussion {#s3}
======================

Vitamin B~12~ availability is essential for class II RNR activity in *P. aeruginosa* growth
-------------------------------------------------------------------------------------------

Vitamin B~12~, or adenosylcobalamin (AdoCob), acts as a radical generator for class II RNR enzyme activity, but the link between vitamin B~12~ biosynthesis and class II RNR (NrdJ) activity in *P. aeruginosa* is poorly understood, and further investigations are required, especially during bacterial biofilm growth.

We first analyzed the essentiality and role of the class II RNR enzyme under aerobic and anaerobic conditions depending on vitamin B~12~ availability. We used diverse *P. aeruginosa* PAO1 strains deficient for different RNR classes (ETS102, Δ*nrdJ*; ETS103, Δ*nrdD*, and ETS125, Δ*nrdJ*Δ*nrdD*) (see Table [1](#T1){ref-type="table"}). We also used a specific mutant strain for the vitamin B~12~ biosynthesis pathway involved in cobalt insertion under aerobic conditions (ETS126, Δ*cobN*). As the *nrdA* mutation is unviable (Sjöberg and Torrents, [@B29]), we added 30 mM hydroxyurea (HU) to mimic an *nrdA* mutant strain. Hydroxyurea interferes with *P. aeruginosa* PAO1 growth, arresting DNA replication by inhibiting NrdA activity (Gale et al., [@B13]; Sjöberg and Torrents, [@B29]; Lee et al., [@B23]; Julian et al., [@B21]).

Aerobically, class Ia RNR inhibition by HU decreased *P. aeruginosa* PAO1 wild-type growth in minimal medium, as previously described (Jordan et al., [@B20]; Torrents et al., [@B33]), but after 48 h of aerobic incubation, some growth was observed (see the undiluted sample 0 with HU in *P. aeruginosa* wild-type and Δ*nrdD*) (Figure [1](#F1){ref-type="fig"}). However, any *P. aeruginosa* with either a class II RNR or a vitamin B~12~ biosynthesis gene mutation (ETS102Δ*nrdJ*, ETS125Δ*nrdJ*Δ*nrdD*, and ETS126Δ*cobN*) treated with HU showed no growth after 48 h (Figure [1](#F1){ref-type="fig"}) or even after 72 h (data not shown). This result indicates that after 48 h of HU treatment, class II RNR remains active and allows *Pseudomonas* growth. Adding vitamin B~12~ into the minimal medium containing 30 mM HU, re-establishes the optimal aerobic growth in the strains encoding an active class II RNR (NrdJ) enzyme (*P. aeruginosa* PAO1 wild-type; ETS103, Δ*nrdD* and ETS126, Δ*cobN* strains). Therefore, vitamin B~12~ availability (from biosynthesis or the environment) supports class II RNR activity and rescues class Ia RNR deficiency by HU inhibition under aerobic conditions. Thus, in this work, we demonstrated that a *cobN* gene mutation disrupted vitamin B~12~ biosynthesis and completely abolished class II RNR activity, inhibiting aerobic bacterial growth (ETS126, Δ*cobN*).

![Effect of hydroxyurea and vitamin B~12~ on *P. aeruginosa* PAO1 wild-type, Δ*nrdJ*, Δ*nrdD*, Δ*nrdJ*Δ*nrdD*, and Δ*cobN* strain growth. Five-microliter drops were plated from a 0, 10^−4^, and 10^−8^ dilution into a solid medium containing 30 mM hydroxyurea (HU) and 1 μg/ml vitamin B~12~ (vit B~12~) for 48 h. Pictures represent three independent experiments.](fmicb-09-00986-g0001){#F1}

However, under anaerobic conditions, class II and III RNR mutants (Δ*nrdJ*, Δ*nrdD*, and Δ*nrdJ*Δ*nrdD*) grew slightly less than the *P. aeruginosa* PAO1 wild-type and Δ*cobN* deficient strains (Figure [1](#F1){ref-type="fig"}). Δ*cobN* mutant strain growth was unaffected anaerobically (undiluted sample, 0). This result suggests that the *cobN* gene was uninvolved in *P. aeruginosa* vitamin B~12~ biosynthesis under anaerobic conditions. Another *Pseudomonas* strain, *P. denitrificans*, was shown to only synthesize vitamin B~12~ aerobically (Roth et al., [@B26]). Thus, *P. aeruginosa* PAO1 cannot sustain proper growth anaerobically unless RNR activity is increased by externally adding vitamin B~12~ to the medium (1 μg/ml) (this work) or by increasing class III RNR gene copy numbers by complementing extra external NrdDG copies \[ETS103 (Δ*nrdD*)+pETS60 (+NrdDG)\] as previously described (Crespo et al., [@B8]). Nevertheless, the vitamin B~12~ anaerobic internalization pathway remains unknown, and more experiments are required.

Therefore, we demonstrated that class II RNR (NrdJ) is active in both aerobic and anaerobic conditions if vitamin B~12~ is available in the medium. However, class Ia and III RNR enzymes preferentially supply the dNTPs required for aerobic (Sjöberg and Torrents, [@B29]) and anaerobic (Crespo et al., [@B8]) bacterial DNA replication, respectively. Lack of class Ia and III RNR activity in planktonic culture, due to class Ia RNR activity inhibition by HU or by low *nrdD* expression levels, causes cell filamentation growth in *P. aeruginosa* PAO1 (Sjöberg and Torrents, [@B29]; Crespo et al., [@B8]), thus increasing its *nrd* expression (Figure [2](#F2){ref-type="fig"}). Adding vitamin B~12~ returns its cellular morphology to rod-shaped by restoring the DNA replication impairment by activating class II RNR (Crespo et al., [@B8]) and slightly decreasing expression of the three *nrd* genes (Figure [2](#F2){ref-type="fig"}), independently of B~12~-riboswitch regulation (Vitreschak et al., [@B34]). Other vitamin B~12~-dependent enzymes (methionine, cobalamin biosynthesis and some ribonucleotide reductases from other microorganisms) are usually regulated by a B~12~-riboswitch on their promoter regions (Vitreschak et al., [@B34]; Borovok et al., [@B5]).

![Expression analysis of the different *P. aeruginosa* PAO1 RNR classes under HU and vitamin B~12~ treatment under aerobic and anaerobic conditions. Cultures were treated in the presence of HU (30 mM) and vitamin B~12~ (1 μg/ml) for 20 min prior to measure the relative fluorescence units of *PnrdA* (pETS134)*, PnrdJ* (pETS180*)* and *PnrdD* (pETS136). The results are the mean of three independent experiments ± standard deviation. Asterisks over bars (^\*^) indicate statistical differences compared to those without treatment (H~2~O) (*p* \< 0.05 in pairwise *t*-test calculated with GraphPad 6.0).](fmicb-09-00986-g0002){#F2}

In addition, *P. aeruginosa* PAO1 planktonic cells treated with HU for 2 h in minimal medium under aerobic conditions cause filamentous morphology (Figure [3](#F3){ref-type="fig"}); however, at 24 h post-HU treatment (late stationary phase), *P. aeruginosa* PAO1 cells return to their rod-shaped morphology without adding external vitamin B~12~ (Figure [3](#F3){ref-type="fig"}), indicating that DNA synthesis was restored only by class II RNR activity. Nevertheless, disrupting vitamin B~12~ biosynthesis using the *P. aeruginosa* PAO1 Δ*cobN* mutant strain causes filamentous cells even after 24 h of HU treatment. These results highlight an active vitamin B~12~ biosynthesis in *P. aeruginosa* PAO1 that specifically requires the *cobN* gene under aerobic stationary growing conditions for class II RNR activity and thus for DNA biosynthesis. However, vitamin B~12~ levels are insufficient during the initial hours of *P. aeruginosa* PAO1 growth (2 h) and likely reach optimal physiological levels of vitamin B~12~ after 24 h. Vitamin B~12~ biosynthesis pathway regulation requires further investigation.

![Cell morphology after hydroxyurea treatment. Fluorescence microscopy images from aerobic *P. aeruginosa* PAO1 wild-type and Δ*cobN* growth visualized after 2 and 24 h of HU treatment. Cells were stained with the LIVE/DEAD BacLight Bacterial Viability Kit, and the bacterial length was measured using ImageJ software. The images represent at least three different experiments. Scale bars, 20 μm.](fmicb-09-00986-g0003){#F3}

*Pseudomonas aeruginosa* cell morphology under anaerobic conditions was filamentous due to the low class III RNR activity (Crespo et al., [@B8]). We also observed that the *P. aeruginosa* PAO1 Δ*cobN* mutant strain cell morphology was similar to the *P. aeruginosa* PAO1 strain, suggesting no vitamin B~12~ biosynthesis during anaerobic growth, even after 16 h (Figure [4](#F4){ref-type="fig"}). Hence, in anaerobic conditions, the *P. aeruginosa* PAO1 and Δ*cobN* strains growth needed external vitamin B~12~ supplementation for optimal class II RNR activity. This was demonstrated previously in the anaerobic *P. aeruginosa* PAO1 growth that was restored with an extra copy of *nrdDG* genes or by adding vitamin B~12~, enhancing RNR activity (Crespo et al., [@B8]).

![CobN is not involved in *P. aeruginosa* PAO1 anaerobic growth. Fluorescence microscopy pictures of *P. aeruginosa* PAO1 wild-type, Δ*cobN*, Δ*nrdJ, and* Δ*nrdJ* + NrdDG cells stained with the LIVE/DEAD BacLight Bacterial Viability Kit at 16 h of anaerobic growth in MM ± vitamin B~12~. The length was measured using ImageJ software. Scale bars, 10 μm.](fmicb-09-00986-g0004){#F4}

Biofilm formation depends on vitamin B~12~ synthesis
----------------------------------------------------

Class II and III RNR enzymes are necessary for biofilm formation when class II RNR is highly expressed (Crespo et al., [@B9]). Currently, it is unknown whether vitamin B~12~ is synthesized and influences class II RNR activity under biofilm conditions. Thus, we analyzed different *P. aeruginosa* strains (wild-type and isogenic mutant strains for *nrdJ, nrdD* and *cobN* genes) grown in a continuous-flow cell biofilm system. Figure [5A](#F5){ref-type="fig"} shows that aerobic biofilm formation in minimal media, measured as total biofilm biomass and average thickness, decreased when class II and III RNR were mutated. We previously reported a similar result for biofilm cells grown in LB-rich media (Crespo et al., [@B9]). The *P. aeruginosa* Δ*cobN* mutant strain (vitamin B~12~ deficient) decreased in biofilm formation compared to the *P. aeruginosa* PAO1 strain, similar to the produced levels in any *P. aeruginosa* deficient for class II RNR (Δ*nrdJ* and Δ*nrdJ*Δ*nrdD*) (Figure [5A](#F5){ref-type="fig"}). Furthermore, the biomass and thickness levels in the *P. aeruginosa* PAO1 Δ*nrdJ* and Δ*nrdJ*Δ*nrdD* mutant strains did not reach the wild-type strain levels even when vitamin B~12~ was added~.~ However, the *P. aeruginosa* PAO1 Δ*nrdD* and Δ*cobN* mutant strain biofilm thickness increased considerably when vitamin B~12~ was added, indicating active class II RNR activity.

![Vitamin B~12~ enables *P. aeruginosa* biofilm formation though class II RNR activity. **(A)** The continuous-flow cell biofilm of *P. aeruginosa* PAO1 wild-type, Δ*nrdJ*, Δ*nrdD*, Δ*nrdJ*Δ*nrdD*, and Δ*cobN* strains was grown for 5 days in MM ± vitamin B~12~ (1 μg/ml). Biomass and thickness were calculated using COMSTAT software. Data are the average of three independent experiments. Asterisks over bars (^\*^) indicate statistical differences (*p* \< 0.005 in pairwise *t*-test calculated with GraphPad 6.0). **(B)** Pictures of the sum and the orthogonal views of biofilms stained with the LIVE/DEAD BacLight Bacterial Viability Kit before visualization by a confocal microscope. Images represent three independent experiments. Bars represent 200 μm.](fmicb-09-00986-g0005){#F5}

These results suggest an active vitamin B~12~ biosynthesis in the *P. aeruginosa* biofilm growth via the *cobN* gene. Moreover, supplying vitamin B~12~ enabled optimum *P. aeruginosa* PAO1 biofilm growth in the biofilm layers without active vitamin B~12~ biosynthesis due to oxygen concentration strengths, activating class II RNR. As expected, cell filamentation morphology, in the Δ*nrdJ* mutants, was restored by adding vitamin B~12~ to the continuous-flow biofilm (Figure [5B](#F5){ref-type="fig"}).

Vitamin B~12~ availability during *P. aeruginosa* aerobic and biofilm growth
----------------------------------------------------------------------------

We described that *P. aeruginosa* needs vitamin B~12~ availability during planktonic and biofilm growth, essential for class II RNR enzymatic activity. Thus, we elucidated for the first time the amount of vitamin B~12~ available for *P. aeruginosa* growth under different conditions (planktonic aerobic or anaerobic and biofilm) in different *P. aeruginosa* strains.

Quantifying vitamin B~12~ by HPLC-MS showed this molecule only in cells that were grown aerobically and in the stationary phase (Table [3](#T3){ref-type="table"}). However, at exponential growth and in anaerobic conditions, vitamin B~12~ was detected below the technique detection limit, corroborating previous results under these conditions. Surprisingly, under 5-day-old continuous-flow biofilm *P. aeruginosa* PAO1 growth, cells produced a 10-fold increase in vitamin B~12~ compared to aerobic growth, indicating this biosynthetic pathway is activated under this circumstance. We suggested that vitamin B~12~ biosynthesis in biofilm is only produced in the upper-aerobic biofilm layer because we detected no vitamin B~12~ levels in cells grown anaerobically (Table [3](#T3){ref-type="table"}). Some studies suggested that vitamin B~12~ (*cob*) aerobic synthesis genes are expressed more during biofilm growth (Anderson et al., [@B2]) in the mucoid phenotype (Rao et al., [@B25]) and the stationary phase (Fung et al., [@B12]), with downregulated anoxic conditions (Alvarez-Ortega and Harwood, [@B1]).

###### 

Quantification of vitamin B~12~ levels by HPLC-MS.

          **ng Vitamin B~12~/mg protein**                         
  ------- --------------------------------- ------------- ------- -------------
  PAO1    0^nd^                             0.32 ± 0.05   0^nd^   3.72 ± 0.01
  PAET1   0^nd^                             0.67 ± 0.06   0^nd^   1.72 ± 0.05
  PA14    0^nd^                             0.51 ± 0.02   0^nd^   0.84 ± 0.01

*Growth of P. aeruginosa PAO1, PAET1 and PA14 strains under aerobic (exponential OD550\~0.5 and stationary OD550\>2) and anaerobic conditions for 20 h (OD550\~2) and under continuous-flow biofilm formation conditions (5 days). Values were normalized by protein concentration. Two independent experiments were performed, and the mean ± standard deviation is shown. nd, denotes Not-detected, below the technique detection limit*.

Previous studies showed different RNR activity in other *P. aeruginosa* strains under aerobic and anaerobic conditions (Crespo et al., [@B8]). Therefore, we analyzed vitamin B~12~ levels in strains more recently isolated, such as the *P. aeruginosa* PA14 and PAET1 strains, and we observed different vitamin B~12~ levels between strains. In *P. aeruginosa* PA14 and PAET1 strains, we identified increased vitamin B~12~ levels under aerobic conditions (1.6 and 2.1 times, respectively) (Table [3](#T3){ref-type="table"}) and lower vitamin B~12~ levels under biofilm growth conditions compared to the *P. aeruginosa* PAO1 strain. These different vitamin B~12~ levels may affect RNR activity and expression (Figure [2](#F2){ref-type="fig"}), but further experiments are required to validate this hypothesis. It may be due to an active class III RNR detected in the most recently isolated strains compared to the *P. aeruginosa* PAO1 strain (Crespo et al., [@B8]).

*P. aeruginosa* clinical isolates grow with hydroxyurea treatment
-----------------------------------------------------------------

Increased vitamin B~12~ availability in the aerobic growth of *P. aeruginosa* PA14 and the clinical isolate PAET1 strains suggests higher class II RNR activity under this growing condition. We evaluated strain growth in cells with class Ia RNR inhibited by adding 30 mM HU, which were only growing with an active class II RNR. The results showed that any *P. aeruginosa* strain could grow when vitamin B~12~ was added (Figure [6A](#F6){ref-type="fig"}). In contrast to *P. aeruginosa* PAO1, the absence of external vitamin B~12~ in *P. aeruginosa* PA14 and the clinical isolate PAET1 strain did not affect their growth aerobically. Therefore, vitamin B~12~ is more available in these strains than in the *P. aeruginosa* PAO1 strain for class II RNR activity.

![*P. aeruginosa* PAET1 and PA14 strains are resistant to HU. **(A)** Growth curve of *P. aeruginosa* PAO1, PAET1 and PA14 strains in MM containing 30 mM hydroxyurea (HU) and 1 μg/ml vitamin B~12~. **(B)** Cells were visualized 4 h after HU treatment. Images and values are representative of three independent experiments ± standard deviation. Bars represent 20 μm. **(C)** Aerobic *P. aeruginosa* PAO1, PAET1 and PA14 strain cell viability with HU and vitamin B~12~ at 20 or 48 h of incubation. Pictures represent three independent experiments. Cultures were diluted to 0, −4, and −8 for the growth.](fmicb-09-00986-g0006){#F6}

Additionally, the cell morphology shown in the *P. aeruginosa* PAO1 strain after 4 h of HU treatment was filamentous (\~10 μm). However, HU treatment of *P. aeruginosa* PA14 and PAET1 yielded rod-shaped cell morphology (1.4 and 1.7 μm), suggesting that their DNA replication was unimpaired (Figure [6B](#F6){ref-type="fig"}) after 4 h of treatment. However, *nrd* gene expression in *P. aeruginosa* clinical isolates strains was increased, suggesting that HU inhibited class I RNR as in the *P. aeruginosa* PAO1 strain (Table [4](#T4){ref-type="table"}). This result was corroborated by analyzing their cell viability in a solid medium under HU treatment with and without vitamin B~12~. *P. aeruginosa* PA14 and PAET1 strains grew in as little as 20 h in the presence of HU (Figure [6C](#F6){ref-type="fig"}) compared with 48 h for *P. aeruginosa* PAO1.

###### 

Expression of *nrdA, nrdJ*, and *nrdD* genes of *P. aeruginosa* PAO1 and clinical isolates (PAET1 and PA14) strains with HU.

          **Log-fold change (HU vs. H~2~O)**                
  ------- ------------------------------------ ------------ -------------
  PAO1    9.19 ± 2.1                           31.65 ± 3    50.46 ± 7.2
  PAET1   27.74 ± 2.1                          7.63 ± 1.1   16.38 ± 0.5
  PA14    4.91 ± 0.8                           1.18 ± 0.2   32.7 ± 0.9

*Fold-change of nrd genes using qRT-PCR after 20 min of treatment with 30 mM HU compared with H~2~O. The gap gene was used as an internal standard. Two independent experiments were analyzed, and the standard deviation was annotated*.

Conclusions {#s4}
===========

We demonstrated that vitamin B~12~ synthesis occurs under *P. aeruginosa* aerobic planktonic growth conditions with an active class Ia RNR that supplies dNTPs required for DNA replication (Figure [7A](#F7){ref-type="fig"}). Vitamin B~12~ cannot be synthesized anaerobically when *P. aeruginosa* cells are grown with class III RNR (Figure [7A](#F7){ref-type="fig"}; Crespo et al., [@B8]). Class II RNR is enzymatically active when vitamin B~12~ is available through internal biosynthesis or from the environment.

![Model of ribonucleotide reductase activity and vitamin B~12~ availability during *P. aeruginosa* planktonic and biofilm growth. Scheme of *P. aeruginosa* growing in **(A)** aerobic and anaerobic planktonic cultures and **(B)** biofilm. Orange circles represent the vitamin B~12~ gradient, blue indicates oxygen concentration gradients and green indicates class Ia, II and III RNR activity.](fmicb-09-00986-g0007){#F7}

*Pseudomonas aeruginosa* growing in biofilm differs and requires a more in-depth analysis. Oxygen diffusion through the complex biofilm structure generates an oxygen concentration gradient with apparent cell distribution with different RNR class activity (Figure [7B](#F7){ref-type="fig"}; Crespo et al., [@B9]). We suggest that in the superficial biofilm layers, aerobic cells express class Ia RNR, whereas in the internal layers, anaerobic conditions require cells to express class II or III RNR (Crespo et al., [@B9]). However, class II RNR is highly expressed during biofilm formation and in aerobic environments (Sjöberg and Torrents, [@B29]; Crespo et al., [@B9]) but is oxygen-independent and vitamin B~12~-dependent (aerobically synthetized). This leads us to ask under which conditions this RNR class enzymatically is active.

We suggest that external cells in a biofilm, which are in contact with aerobic environments, can synthesize vitamin B~12~, and it can diffuse through the biofilm structure creating a vitamin B~12~ concentration gradient along this structure. In this sense, class II RNR can be active in areas with microaerophilic conditions where class Ia or class III RNR are inactive (Figure [7B](#F7){ref-type="fig"}). Consequently, these results bring us closer to understanding the *P. aeruginosa* cell division mechanism through dNTP synthesis in planktonic and biofilm conditions.
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